Phase 2 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial has three separate groups. Please read the group that may apply to you:
Group 1 – Heart Failure with Preserved Ejection Fraction (HFpEF):
- You are 30 years of age or older and experience shortness of breath during physical activity
- Your heart is pumping normally (as confirmed by a doctor), but you still have heart failure symptoms
- Your body mass index (BMI) is 30 or above (considered obese range)
- You have been newly diagnosed with this type of heart failure through a specialised heart pressure test (confirm with trial site)
Group 2 – Cardiac Sarcoidosis:
- You are 18 years of age or older and are able to attend appointments as an outpatient (not currently hospitalised)
- You have recently been referred to a Sarcoidosis clinic with a confirmed but not yet treated diagnosis of cardiac sarcoidosis
- You have had a specific type of heart scan (18F-FDG PET scan) within the last 30 days that showed positive results
Group 3 – Healthy Volunteers:
- You are 30 years of age or older
- You do not have any major long-term health conditions affecting your heart, lungs, immune system, kidneys, liver, or a history of cancer
- You do not regularly take medications such as blood thinners, blood pressure tablets, diabetes medications, immune-suppressing drugs, or similar (confirm with trial site for full list)
Who may not be able to join:
Group 1 – Heart Failure (HFpEF):
- You have a primary heart muscle disease, disease around the heart, or significant heart valve problems
- Your shortness of breath is caused by a lung condition or blocked heart arteries
- You have severe anaemia (low red blood cells), or severe liver or kidney disease
- You currently have active cancer
- You have an active inflammatory or autoimmune condition such as rheumatoid arthritis or lupus
- You were hospitalised in the last 30 days, or had a procedure to open blocked heart arteries in the last 90 days
- You are already taking certain diabetes or weight-loss medications called SGLT2 inhibitors or GLP-1 agonists (confirm with trial site for specific drug names)
- You are pregnant or breastfeeding
- You are unable to lie flat for the required scans
- You have severe claustrophobia, a cochlear implant, an implanted nerve stimulator, or other reasons you cannot safely have an MRI scan
- You have a known allergy to gadolinium (a dye used in MRI scans)
- You have a pacemaker, an implanted defibrillator, or an artificial heart valve
Group 2 – Cardiac Sarcoidosis:
- You are already taking medications that suppress your immune system
- You are pregnant or breastfeeding
- You have severe liver or kidney disease, or are on dialysis
- You had a procedure to open blocked heart arteries in the last 90 days
- You currently have active cancer
- You have a known allergy to gadolinium (a dye used in MRI scans)
- You are unable to lie flat for the required scans
- You have severe claustrophobia, a cochlear implant, an implanted nerve stimulator, or other reasons you cannot safely have an MRI scan
- You have a pacemaker, an implanted defibrillator, or an artificial heart valve
Group 3 – Healthy Volunteers:
- Your BMI is 30 or above
- You are pregnant or breastfeeding
- You have a known allergy to gadolinium (a dye used in MRI scans)
- You are unable to lie flat for the required scans
- You have severe claustrophobia, a cochlear implant, an implanted nerve stimulator, or other reasons you cannot safely have an MRI scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Omar Abou Ezzeddine, M.D, M.S, Mayo Clinic
Phone: 507-422-9485
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Myocardial 68Ga-FAPI (68Ga-Fibroblast Activation Protein Inhibitor) volume; Mean Standardized Uptake Value (SUVmean) and Max Standardized Uptake Value (SUVmax); Area of 68Ga-FAPI (68Ga-Fibroblast Activation Protein Inhibitor) uptake; 68Ga-FAPI target-to-background ratio
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.